RSS | Login | Register

Marc Iskowitz

Recent Articles

Case study—Nuvigil: Pay for Play

February 06, 2012

Performance-based e-marketing may rival mass-media reach for less money, Marc Iskowitz finds

Allergan scrubs some doc-payment data, spares med-ed grants

February 03, 2012

Allergan removed records from its website that had detailed payments made to doctors from the middle of 2010 through first-half 2011.

Jobson Medical files for chapter 11 debt relief

February 03, 2012

Jobson Medical Information Holdings filed for chapter 11 bankruptcy in New York Thursday, the company said, part of an effort to amend and extend its credit and strengthen its balance sheet.

GSK divests OTC brands, Prestige picks them up

February 01, 2012

GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.

Patient Education: Vying for Attention

February 01, 2012

Marc Iskowitz on how Shire's disease-awareness campaign engaged untreated Gen Y-ers, and why it's time for more patient-education efforts like it. Plus: See patient advocates discuss the ADHD market

Tamiflu review raises questions

February 01, 2012

A systematic review of Roche's antiviral drug Tamiflu appearing in last month's Cochrane Library has led to questions about the data's efficacy, as well as Roche's commitment to provide sufficient data.

NEJM celebrates 200 years

February 01, 2012

The New England Journal of Medicine celebrates its 200th aniversary by producing a series of review articles and perspective pieces by established authors